Several new antimicrobial candidate drugs that share enzyme targets with fluoroquinolones but act through distinct binding sites dominated the poster summary session "Early New Antimicrobial Agents" at the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Denver, Colo., last September. Other hopefuls include a narrow-spectrum DNA synthesis inhibitor that is active against Clostridium diffıcile, improved drug candidates that target the type III secretion apparatus of gram-negative bacterial pathogens, and a series of broad-spectrum ␤-lactamase inhibitors that help overcome resistance in pathogens to ␤-lactam antibiotics.
GSK2140944 (GSK944) is a novel bacterial topoisomerase inhibitor that differs from fluoroquinolones (FQ) in how it inhibits the same target enzymes, according to John Payne of GlaxoSmithKline (GSK) in Collegeville, Pa. Indeed, GSK944, which binds uncleaved DNA, is active against many bacterial pathogens that are resistant to FQ antibiotics, which bind instead to cleaved DNA, he says. X-ray crystallographic analysis confırms that the binding site of GSK944 on DNA gyrase differs from that of FQ antibiotics.
GSK944 is active against a range of conventional gram-positive bacterial pathogens as well as several biothreat pathogens, including Yersinia pestis and Bacillus anthracis. One pathogen against which it is not active is Chlamydia pneumoniae-"one of the surprises you get when working with a novel class," he says.
The benzisoxazoles are another group of antibacterial compounds that target DNA gyrase and topoisomerase, but with a mechanism that is distinct from FQ antibiotics (and presumably from GSK944, too), according to John Mueller of AstraZeneca in Waltham, Mass. These agents appear to have a dual target, at least when evaluated for activity against Staphylococcus aureus in vitro, he says. Among the benzisoxazoles, AZD0914 is "highly active" against clinical isolates of Neisseria gonorrheae, including those that are resistant to ciprofloxacin, he says. Whether it or other gyrase inhibitors in this class are similarly active against C. trachomatis, another sexually transmitted bacterial pathogen, remains to be tested.
Like FQ antibiotics, fused 2-pyridone compounds belonging to a newly disclosed PTC series are dual inhibitors of DNA gyrase and topoisomerase bacterial enzymes, according to Gary Karp of PTC Therapeutics in South Plainfıeld, N.J. Some compounds in this series show potent activity against a broad array of drug-resistant-including to fluoroquinolones-gram-negative and gram-positive bacterial pathogens, he says. Structural adjustments lead to some compounds within this series with "quite good activity against N. gonorrhea," including multipledrug-resistant isolates of this pathogen.
Although the structurally unrelated compound SMT19969 also inhibits DNA synthesis, its precise molecular target is not known but under study, according to Richard Vickers of Summit PLC in Abingdon, United Kingdom. This novel antimicrobial agent is "highly active and bactericidal" against C. diffıcile, he says. In part because of its narrow activity and apparent superiority to vancomycin, SMT19969 is already entered into clinical trials. It has another advantage in having little activity against other bacterial species of the gastrointestinal tract, including other clostridial species, based in part on analysis of fecal samples from the phase 1 clinical trial, he adds. A phase 2 clinical trial is planned for 2014.
MINITOPIC

GAO Report, Rep. DeLauro Raise Meat Safety Concerns
Officials of the US Department of Agriculture (USDA) need better information on a pilot project involving facilities for hogs and, separately, to bolster a proposed rule that affects inspections of poultry slaughter facilities, according to a report, "More Disclosure and Data Needed to Clarify Impact of Changes to Poultry and Hog Inspections," issued by the Government Accountability Office (GAO) last August. The GAO report criticizes the USDA Food Safety and Inspection Service (FSIS) for not thoroughly evaluating projects that are part of a broader effort to modernize food safety inspection procedures. In a related development, Representative Rosa DeLauro (D-CT) raised concerns with FSIS officials over "ongoing problems" with its Public Health Information System, saying that it continues to be "riddled with problems since its rollout over 2 years ago." Separately, Rep. DeLauro is objecting to USDA over its plans to grant "China's poultry processing plants standards of food safety equivalency to those in the United States." China's "food safety record should be deeply worrisome to American consumers," she says.
Unlike agents that inhibit DNA gyrase and topoisomerase or other steps in DNA synthesis, the phenoxyacetamides target the type III secretion apparatus of gram-negative pathogens, particularly Pseudomonas aeruginosa, according to Donald Moir of Microbiotix in Worcester, Ma. A recently improved stereoselective member of this class proves to be "highly potent" against this gram-negative pathogen, he says. Mutational and deep-sequencing analyses suggest that these antimicrobial agents target the needle protein in the type III secretion assembly. Moreover, the latest inhibitors of this class are active at concentrations below 1 M, and are active against P. aeruginosa pneumonia in rodents.
Not antibacterial on its own, FPI-1465 and other substituted amides with diaza bicyclic heterocyclic rings are potent, broad-spectrum ␤-lactamase inhibitors, according to Tom Parr of Fedora Pharmaceuticals in Edmonton, Alberta, Canada. This compound seems to do best when combined with meropenem, but he and his collaborators are open to combining it with other ␤-lactam antibiotics, he says. For example, FPI-1465 shows "strong synergy" when used with ceftazidime against gram-negative bacterial pathogens in vitro.
Jeffrey L. Fox is the Microbe Current Topics and Features Editor.
RESEARCH ADVANCES
Microbes Occupy, May Be Degrading Plastic Debris in Oceans Carol Potera
Plastic, the most common debris contaminating ocean ecosystems, supports and is contaminated by complex microbial communities, called the "plastisphere." These microbes colonize and may help to degrade plastic polymers, according to Linda Amaral-Zettler at the Marine Biological Laboratory (MBL) and her collaborators there and at the Woods Hole Oceanographic Institution (WHOI), both in Woods Hole, Mass. Details appear July 13, 2013 in Environmental Science & Technology [doi:10.1021 .
While cruising the Sargasso Sea, the MBL and WHOI researchers collected plastic debris from the Atlantic Ocean. The plastic pieces that were recovered, largely polyethylene and polypropylene, averaged less than 5 mm in diameter. The recovered pieces are pitted, and many types of bacteria are embedded within those pits, the researchers report, basing their conclusions on scanning electron microscopy and genotyping analysis. The variety and type of microbes found as part of the floating plastisphere afford hope that plastic debris might not be a fully permanent fıxture of the marine environment.
More than 1,000 bacterial species can be detected within those pits, including species that are closely related to known hydrocarbon-degrading specialists such as the fılamentous cyanobacterium Phormidium, members of the Chloroflexi, and Myxococcales, according to Amaral-Zettler, who takes credit for coining the term plastisphere during the 5th International Marine Debris Conference in 2011. "We're working to identify them and their function," she says.
The microbial species associated with the plastisphere are more diverse and abundant than those measured in surrounding seawater, according to Amaral-Zettler and her collaborators. To their surprise, vibrios made up 24% of the bacterial community on some plastic pieces, whereas, in seawater, vibrios rarely account for more than 1% of the microbial population, she says, noting: "Some vibrios we picked up are potential pathogens to humans, animals, fısh, and coral." Birds and fısh that ingest such plastic debris may in this way be exposed to higher than usual levels of potentially infectious microorganisms, she points out.
The microbes living in the plastisphere might yield chemical compounds with useful properties, including some with antimicrobial activity, according to Tracy Mincer at WHOI, another member of this research group. "We're getting good hits on new molecules," he says.
Plastisphere research "opens a door for potentially interesting future fınd-ings," says Edward Carpenter of the MINITOPIC Viruses: New Totals Projected, Surprise Origins for Some "There aren't millions of unknown viruses, just a few hundred thousand," says Peter Daszak, president of EcoHealth Alliance in New York, N.Y., who was speaking for his collaborators there and from several other institutions, including the Columbia University Mailman School of Public Health. These researchers say that their initial estimate of 320,000 viruses overall is "just a starting point" and suggest that this figure will "likely be considerably higher after accounting for additional viral families and employing highthroughput sequencing methods." Details appear September 3, 2013 in mBio (doi:10.1128/mBio.00598-13). Separately, other researches disclosed surprising findings about the origins of a particular set of viruses. Specifically, the avian retroviruses called reticuloendotheliosis viruses apparently derive from mammalian retroviruses that were "accidentally introduced into avian hosts during experimental studies of a malaria parasite in the late 1930s," report Robert Gifford and Anna Maria Niewiadomska of the Aaron Diamond AIDS Research Center, also in New York. Details appear August 27, 2013 in PLoS Biology (11(8): e1001642. doi:10.1371/journal.pbio. 1001642).
